Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin

Aseptika recognised as a leading HealthTech Innovator with listing as 2017 Global Digital Health 100

0

22nd January, 2018: St Ives, Cambridgeshire.  Aseptika Limited (Activ8rlives) has again been recognised as a leading HealthTech Innovator by their listing in the 2017 Global Digital Health 100 List.

The Global Digital Health 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered. Over the past four years, the Global Digital Health 100 has become established as the international benchmark of innovation in the healthcare technology industry and this is the third time Aseptika (Activ8rlives) has been included in the top 100.  For more details and to view the full 2017 Global Digital Health 100 visit thejournalofmhealth.com/digital-health-100.

Digital Health is Maturing
The awards programme run by the Journal of mHealth commented, “reflect the ever-growing importance of mobile, digital and connected solutions in the healthcare industry, the Global Digital Health 100-2017 recognises the significant work being carried out by organisations from around the globe.

While many companies, over the past few years, have failed despite having truly innovative technologies to offer, the 2017 cohort shows that it is essential to not only demonstrate innovation in technology, but also innovation in service and business model development as a requisite to succeeding as a technology company in the healthcare industry”.

Identifying the 100
The judging criteria analysed 10 different quantitative and qualitative evaluation metrics including: disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and, industry integration. The selected 100 companies demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria ensure that companies are considered truly upon innovation, allowing start-up offerings to be compared alongside established and larger organisations.

Share.

Comments are closed.